Fluconazole vs. Itraconazole for Pityriasis Versicolor
Fluconazole
+ Itraconazole
Bacterial Infections and Mycoses+5
+ Dermatomycoses
+ Infections
Treatment Study
Summary
Study start date: March 1, 2025
Actual date on which the first participant was enrolled.Pityriasis versicolor is a skin condition caused by a fungus, leading to patches on the skin that can be lighter or darker than the surrounding areas. This study focuses on comparing two medications, fluconazole and itraconazole, which are both taken orally to treat this condition. The goal is to determine which medication is more effective in treating pityriasis versicolor. This is important as finding the more effective treatment could improve care for those suffering from this common skin infection. In this study, participants will receive either fluconazole or itraconazole orally. Researchers will observe the effects of these medications on the skin condition over time. The study does not specify particular outcomes being measured, but typically, effectiveness would be assessed by the improvement in skin appearance and reduction in fungal infection. Participants might experience side effects from the medications, as is common with oral antifungal treatments, but the study aims to identify which drug provides better results with the least issues.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.106 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 50 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
This study does not include a placebo group
Treatment Groups
Group I
ExperimentalGroup II
ExperimentalStudy Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location